NextPharma appoints three new senior team members

NextPharma Technologies Holding Limited, one of the leading contract manufacturers in Europe for the pharmaceutical, biotechnology and healthcare industries, is delighted to announce the appointment of two key additions to its executive team. Andrew Kelley has been appointed Chief Operating Officer and Pierre Delavaud has been appointed Executive Vice President Sales and Marketing. In addition, Matthew Wilder has been appointed Vice President US Sales and Marketing to help drive the company’s business in the United States.

Andrew brings over 27 years of experience in the pharmaceutical industry, with a strong track record leading manufacturing operations, most recently at Patheon. Pierre has a strong background in sales and marketing in the pharmaceutical industry and joins the team from SkyePharma, having previously spent 14 years at Catalent, where he held various senior positions. Matthew has over ten years of sales and marketing experience in the US pharmaceutical industry and joins NextPharma from Sanofi Pharmaceuticals, where he held various senior positions.

Franck Latrille, Chief Executive Officer, NextPharma, commented: “We are delighted to welcome our three new colleagues to our growing team at NextPharma. This is an exciting time for the company, and we are confident that with the injection of their expertise to the team, we can continue to improve our business offerings.”